Despite several studies indicating a correlation between PLK1 expression and the aggressiveness of cancers, including CRC, the specific role of PLK1 in the metastatic progression of CRC and the mechanisms driving PLK1-induced EMT remain under active investigation. This evidence concerns the gene PLK1 and colorectal carcinoma.